Glioblastoma Clinical Trials in New York, NY

Glioblastoma Clinical Trials in New York, NY

View the best 10 glioblastoma medical studies in New York, New York. Access promising new therapies by applying to a New York-based Glioblastoma clinical trial.

Trials in New York, New York

Here are the top 8 medical studies for glioblastoma in New York, New York

Image of Children's Oncology Group in Philadelphia, United States.

Selinexor +1 More

Selective Inhibitors of Nuclear Export

Recruiting1 awardPhase 1 & 2
This trial tests the safety and effectiveness of combining selinexor with radiation therapy in children and young adults with aggressive brain tumors. Selinexor is a drug that blocks a protein to stop cancer cells from growing. The study aims to find the best dose and see if this combination can shrink tumors.
Image of City of Hope Comprehensive Cancer Center LAO in Duarte, United States.

Selinexor +1 More

Selective Inhibitor of Nuclear Export

Recruiting1 awardPhase 1 & 2
This trial tests selinexor with temozolomide for patients whose brain cancer has returned. Selinexor blocks a protein that helps cancer cells grow, and temozolomide damages their DNA to kill them or stop their growth. Temozolomide is a DNA methylating drug currently used as a first-line treatment in glioblastoma therapy.
Image of Children's Hospital Los Angeles in Los Angeles, United States.

BGB-290 +1 More

PARP Inhibitor

Recruiting1 awardPhase 1
This trial studies the safety and best dose of BGB-290 and temozolomide in treating young people with a specific type of brain tumor. BGB-290 blocks enzymes needed for tumor growth, while temozolomide kills or stops cancer cells from growing. The goal is to find out if this combination works better for these patients.
Image of Phoenix Childrens Hospital in Phoenix, United States.

Dabrafenib +1 More

Kinase Inhibitor

Recruiting3 awardsPhase 4
This trial is studying the effects of two cancer medications, dabrafenib and trametinib, in children. These drugs work by stopping signals that make cancer cells grow. Dabrafenib and trametinib have shown benefits in various BRAF-mutant tumors, including melanoma, lung cancer, and thyroid cancer. The goal is to see how these treatments affect children over time.
Image of Sunnybrook Health Sciences Centre in Toronto, Canada.

Adaptive, two-phase RT

Radiation Therapy

Recruiting1 award
This trial will test an adaptive two-phase radiation therapy approach to see if it better controls glioblastoma than standard radiation therapy. It will also monitor survival, side effects and quality of life.
Image of Grandview Cancer Center in Birmingham, United States.

OptuneĀ®

Device

Recruiting1 award12 criteria
This trial is testing a new treatment for brain cancer that combines Optune with radiation and chemotherapy. The goal is to see if this new combination is more effective and has fewer side effects than current treatments.
Image of Centralia Oncology Clinic in Centralia, United States.

Lomustine +2 More

Alkylating agents

Recruiting2 awardsPhase 3
This trial is comparing the effect of adding lomustine to temozolomide and radiation therapy versus temozolomide and radiation therapy alone in treating newly diagnosed MGMT methylated glioblastoma.
Image of University of Alabama at Birmingham Cancer Center in Birmingham, United States.

Ipilimumab +2 More

Checkpoint Inhibitor

Recruiting1 awardPhase 2 & 3
This trial is testing whether adding immunotherapy to radiation therapy can help people with newly diagnosed glioblastoma that has an unmethylated MGMT.

Trials With No Placebo

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' ā€” so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back ā€” in general, verified trials respond to patients within a few days.